ENTA
Price
$5.23
Change
-$0.32 (-5.77%)
Updated
May 13 closing price
Capitalization
111.57M
89 days until earnings call
NKTR
Price
$0.71
Change
-$0.00 (-0.00%)
Updated
May 13 closing price
Capitalization
132.13M
85 days until earnings call
Ad is loading...

ENTA vs NKTR

Header iconENTA vs NKTR Comparison
Open Charts ENTA vs NKTRBanner chart's image
Enanta Pharmaceuticals
Price$5.23
Change-$0.32 (-5.77%)
Volume$170.99K
Capitalization111.57M
Nektar Therapeutics
Price$0.71
Change-$0.00 (-0.00%)
Volume$3.05M
Capitalization132.13M
ENTA vs NKTR Comparison Chart
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTA vs. NKTR commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a Buy and NKTR is a Buy.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (ENTA: $5.23 vs. NKTR: $0.71)
Brand notoriety: ENTA: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 77% vs. NKTR: 134%
Market capitalization -- ENTA: $111.57M vs. NKTR: $132.13M
ENTA [@Biotechnology] is valued at $111.57M. NKTR’s [@Biotechnology] market capitalization is $132.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTA is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 4 TA indicator(s) are bullish while NKTR’s TA Score has 5 bullish TA indicator(s).

  • ENTA’s TA Score: 4 bullish, 3 bearish.
  • NKTR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than ENTA.

Price Growth

ENTA (@Biotechnology) experienced а +3.56% price change this week, while NKTR (@Biotechnology) price change was +10.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.76%. For the same industry, the average monthly price growth was +7.67%, and the average quarterly price growth was -5.25%.

Reported Earning Dates

ENTA is expected to report earnings on Aug 11, 2025.

NKTR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($132M) has a higher market cap than ENTA($112M). ENTA YTD gains are higher at: -9.043 vs. NKTR (-23.656). NKTR has higher annual earnings (EBITDA): -86.7M vs. ENTA (-94.42M). NKTR has more cash in the bank: 255M vs. ENTA (217M). ENTA has less debt than NKTR: ENTA (57.5M) vs NKTR (103M). NKTR has higher revenues than ENTA: NKTR (98.4M) vs ENTA (66.6M).
ENTANKTRENTA / NKTR
Capitalization112M132M85%
EBITDA-94.42M-86.7M109%
Gain YTD-9.043-23.65638%
P/E RatioN/AN/A-
Revenue66.6M98.4M68%
Total Cash217M255M85%
Total Debt57.5M103M56%
FUNDAMENTALS RATINGS
ENTA vs NKTR: Fundamental Ratings
ENTA
NKTR
OUTLOOK RATING
1..100
1163
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6161
P/E GROWTH RATING
1..100
182
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NKTR's Valuation (73) in the Biotechnology industry is in the same range as ENTA (96). This means that NKTR’s stock grew similarly to ENTA’s over the last 12 months.

NKTR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ENTA (100). This means that NKTR’s stock grew similarly to ENTA’s over the last 12 months.

NKTR's SMR Rating (98) in the Biotechnology industry is in the same range as ENTA (98). This means that NKTR’s stock grew similarly to ENTA’s over the last 12 months.

NKTR's Price Growth Rating (61) in the Biotechnology industry is in the same range as ENTA (61). This means that NKTR’s stock grew similarly to ENTA’s over the last 12 months.

ENTA's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for NKTR (82). This means that ENTA’s stock grew significantly faster than NKTR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENTANKTR
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 7 days ago
68%
Bullish Trend 20 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Ad is loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ALEC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
-5.77%
ALEC - ENTA
39%
Loosely correlated
-7.50%
NKTR - ENTA
38%
Loosely correlated
-0.67%
BEAM - ENTA
38%
Loosely correlated
-1.04%
ADCT - ENTA
37%
Loosely correlated
-1.49%
EDIT - ENTA
37%
Loosely correlated
-2.60%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with CRSP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-0.67%
CRSP - NKTR
48%
Loosely correlated
-0.98%
IPSC - NKTR
47%
Loosely correlated
+0.25%
NTLA - NKTR
46%
Loosely correlated
-2.69%
DNLI - NKTR
44%
Loosely correlated
-3.65%
RXRX - NKTR
44%
Loosely correlated
-2.80%
More